4740 Green River Road
Suite 307
Corona, CA 92880
United States
714-522-6700
https://www.sohm.com
Sektor(en): Healthcare
Branche: Drug Manufacturers - Specialty & Generic
Vollzeitmitarbeiter: 145
Name | Titel | Zahlen | Ausgeübt | Geburtsjahr |
---|---|---|---|---|
Mr. Shailesh Shah | Chairman, CEO, President, CEO of US, India & Global Ops and President of US, India & Global Ops | N/A | N/A | 1966 |
Dr. David Aguliar Ph.D. | Chief Operating Officer | N/A | N/A | N/A |
Ms. Swati Shah | Vice President, Secretary, Treasurer and Director | N/A | N/A | N/A |
SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.
SOHM, Inc.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.